Regencell Bioscience Holdings Limited

NASDAQ (USD): Regencell Bioscience Holdings Limited (RGC)

Last Price

35.53

Today's Change

-27.813 (43.90%)

Day's Change

32.13 - 58.70

Trading Volume

1,903,160

Overview

Market Cap

17 Billion

Shares Outstanding

494 Million

Avg Volume

4,772,275

Avg Price (50 Days)

11.83

Avg Price (200 Days)

3.12

PE Ratio

-3576.19

EPS

-0.01

Earnings Announcement

26-Jun-2025

Previous Close

63.35

Open

54.57

Day's Range

32.1301 - 58.7055

Year Range

0.079737 - 83.6

Trading Volume

1,909,749

Price Change Highlight

1 Day Change

-43.55%

5 Day Change

116.48%

1 Month Change

202.30%

3 Month Change

2930.67%

6 Month Change

27521.77%

Ytd Change

28094.50%

1 Year Change

33874.82%

3 Year Change

3151.08%

5 Year Change

12842.20%

10 Year Change

12842.20%

Max Change

12842.20%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment